ImportRefusal LogoImportRefusal

BOLISE CO LIMITED

⚠️ Moderate Risk

FEI: 3040362593 • Shanghai, Shanghai • CHINA

FEI

FEI Number

3040362593

📍

Location

Shanghai, Shanghai

🇨🇳

Country

CHINA
🏢

Address

168 Zhonggu Rd, , Shanghai, Shanghai, China

Moderate Risk

FDA Import Risk Assessment

44.4
LowModerateHighCritical

This firm has a moderate history of FDA import refusals. Some attention may be warranted.

Statistics

1
Total Refusals
7
Unique Violations
11/25/2025
Latest Refusal
11/25/2025
Earliest Refusal

Score Breakdown

Violation Severity
51.4×40%
Refusal Volume
11.2×30%
Recency
97.5×20%
Frequency
10.0×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

1181×

NOT LISTED

It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).

22801×

DIRSEXMPT

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a drug within the meaning of Section 201(g) and it lacks adequate directions for use.

32801×

FRNMFGREG

The article is subject to refusal of admission pursuant to section 801(a)(3) in that it appears to be misbranded as defined in section 502(o) of the FD&C Act. It appears that it was manufactured, prepared, propagated, compounded, or processed in an establishment not duly registered under section 510 of the Act.

3331×

LACKS FIRM

The article is in package form and appears to not bear a label containing the name and place of business of the manufacturer, packer, or distributor.

3361×

INCONSPICU

Information required by the Act to be on the label or labeling does not appear to be conspicuous enough as to render it likely to be read and understood by the ordinary individual under customary conditions of purchase and use.

4831×

DRUG NAME

The article appears to be a drug and fails to bear the proprietary or established name and/or name and quantity of each active ingredient.

751×

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

Refusal History

DateProductViolationsDivision
11/25/2025
56FYY99PEPTIDE N.E.C.
118NOT LISTED
2280DIRSEXMPT
3280FRNMFGREG
333LACKS FIRM
336INCONSPICU
483DRUG NAME
75UNAPPROVED
Division of Southeast Imports (DSEI)

Frequently Asked Questions

What is BOLISE CO LIMITED's FDA import refusal history?

BOLISE CO LIMITED (FEI: 3040362593) has 1 FDA import refusal record(s) in our database, spanning from 11/25/2025 to 11/25/2025.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. BOLISE CO LIMITED's FEI number is 3040362593.

What types of violations has BOLISE CO LIMITED received?

BOLISE CO LIMITED has been cited for 7 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about BOLISE CO LIMITED come from?

All FDA import refusal data for BOLISE CO LIMITED is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.